Lacrimal Devices Market Analysis

Lacrimal Devices Market Analysis

The lacrimal devices market based on product is segmented into intubation sets, tubes, stents, cannula & spatula, dilators, punctal plugs and others. The stents segment accounted for 26.8% revenue share in 2021. Lacrimal stents are small tubes commonly made up of silicon. These stents are used to maintain the patency of lacrimal pathway between the nasal passage and surface of the eye. Also, these stents provide suitable circumferential force to facilitate post dacryocystorhinostomy (DCR) healing. Such advantages associated with lacrimal stents are expected to boost the market expansion in the forecast period. Additionally, lacrimal stents are successful in maintaining the patency of the drainage system in laceration of canaliculi, obstruction, and stenosis among others.
 

By application, the lacrimal devices market is segmented into dry eye, epiphora, glaucoma, drainage obstruction, lacrimal gland inflammation and others. Dry eye segment is expected to witness lucrative CAGR of 3.4% in the analysis timeframe. Increasing age, side effect of certain drugs like antihistamines causes dry eyes syndrome. For instance, according to the statistics of dry eye directory, in 2022, between 5-15% of population in America have dry eyes.  Therefore, dry eye can cause lasting damage to the corneal surface and reduce the vision if untreated. Also, leads to the dysfunction of the lacrimal glands that also causes inflammation. Thus, increasing incidence of dry eyes disease across the globe will augment the market size.
 

By end-use, the lacrimal devices market is segmented into hospitals, ophthalmic clinics, diagnostic centers, and others. Hospital segment is expected to reach USD 86.4 million by 2028. The high segmental growth is attributed to developed infrastructure, availability of well-equipped along with advanced technological tools. Moreover, presence of large number of skilled doctors for effective diagnosis & treatment and nursing staff for proper care is boosting the segmental growth.
 

North America dominated the global lacrimal devices market with revenue share of 34.3% in 2021. Increasing incidence of eye diseases coupled with the availability of technologically advanced products is expected to propel the regional market share. Also, increasing disposable income and growing awareness for secure treatment for various eye disorders are few of the other factors boosting the North American market outlook. Furthermore, rising adoption of technological advance tools for effective surgeries and improved patient outcome coupled with presence of key market players will further enhance the market size of North America lacrimal devices.